Trial intelligence / Profile preview

Intranasal vs Intravenous Fentanyl for Procedural Pain in Preterm Neonates

NCT07190625Phase 1Recruiting

Sponsor
Ain Shams University
Start
Dec 2023
Primary completion
Mar 2026
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of fentanyl citrate nasal spray in procedural pain (3 arms), sponsored by Ain Shams University. Primary endpoint: Premature Infant Pain Profile Score at 5 months. Started Dec 2023; status: recruiting.

02

Drugs

fentanyl citrate nasal spray
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT07190625.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07190625.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call